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Background/aim: The severity of disease outcome in dyspepsia has been attributed to Helicobacter pylori virulence genes. The aim of
this study was to determine the distribution of H. pylori virulence genes (cagA, babA2, and dupA) and to determine whether or not there
arises a significant correlation with clinical dyspepsia outcomes.
Materials and methods: H. pylori genotypes cagA, babA2, and dupA were identified by polymerase chain reactions from gastric biopsy
samples in 105 H. pylori-positive patients.
Results: The positive rates for cagA, babA2, and dupA genes in H. pylori dyspeptic patients were 69.5%, 41.0%, and 22.9%, respectively.
cagA was more prevalent in Indians (39.7%), babA2 was more prevalent in Malays (39.5%), and dupA detection occurred more
frequently in both Indians and Malays and at the same rate (37.5%). The Chinese inhabitants had the lowest prevalence of the three
genes. Nonulcer disease patients had a significantly higher distribution of cagA (76.7%), babA2 (74.4%), and dupA (75.0%). There was
no apparent association between these virulence genes and the clinical outcomes.
Conclusion: The lower prevalence of these genes and variations among different ethnicities implies that the strains are geographically
and ethnically dependent. None of the virulence genes were knowingly beneficial in predicting the clinical outcome of H. pylori infection
in our subjects.
Key words: Helicobacter pylori, cagA, babA2, dupA, ethnicity, virulence genes

1. Introduction
Helicobacter pylori affects more than half of the world’s
population and over 70% of those inflicted reside in
developing countries (1). H. pylori colonizes the gastric
mucosa, causing chronic gastritis, peptic ulcers, gastric
adenocarcinoma, and gastric mucosa-associated lymphoid
tissue lymphoma (2,3). The clinical outcome linked to
these diseases has been associated with host genetic
factors, environmental factors, and pathogen virulence
factors (4). A number of proteins, including vacA, cagA,
babA, dupA, SabA, and iceA, have been inferred to play
a vital role in the virulence of H. pylori by increasing the
severity of the disease outcome (5‒8).
The cytotoxin-associated gene (cagA) is most
commonly associated with cytotoxin production and the
induction of interleukin 8 (IL-8) by gastric epithelial cells
* Correspondence: zilfalil2@hotmail.com
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(9). The cag pathogenicity island (PAI), in which the cagA
gene is localized at one end, is involved in the induction
of gastric IL-8 production, though most reports have
demonstrated that the cagA protein is not involved in IL-8
induction (10,11). However, one study has verified that
cagA participates in IL-8 induction in a strain-dependent
and time-dependent manner (12). cagA is deemed to
be one of the most imperative virulence factors in the
pathogenesis of H. pylori. cagA belongs to a cag PAI that
codes a type IV secretion system and this secretion system
is responsible for the translocation of cagA into host cells
(13). In Western countries, cagA-positive strains are
reported to be linked with severe clinical outcomes, but in
East Asian countries, it remains abstruse when trying to
find this link because almost all H. pylori strains possess
cagA (14).
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babA is a blood-group antigen-binding adhesin
encoded by the babA2 gene, which has been shown to bind
H. pylori to human Lewis b blood-group (Leb) antigens
on gastric epithelial cells (15). Although three bab alleles
have been identified (babA1, babA2, and babB), only the
babA2 gene product is functional for Leb binding activity
(16). Some studies discovered a significant relation
between babA2 positive genotypes and the occurrence of
peptic ulcer diseases (12), while others failed to find these
relationships (17,18).
The duodenal ulcer (DU)-promoting gene (dupA) was
initially described by Lu et al. in a study examining 14 vir
gene homologs and their association with gastroduodenal
disease, and especially with DU; hence, the gene was
named dupA (6). dupA has been linked to an increased
risk of DU and protection against gastric atrophy,
intestinal metaplasia, and gastric cancer in Japan and
Korea (6). Although some researchers have supported Lu
et al.’s theory, others have found no such association. A
study conducted within the Iraqi population reported that
dupA is associated with peptic ulcers (19). In comparison,
Argent et al. did not discover any correlation between
dupA and DU in populations from Belgium, South Africa,
China, and the United States (20).
The Malaysian population is divided into three
ethnic groups (Malay, Chinese, and Indian) and these
groups reflect differences in H. pylori infection. There are
variations regarding the association between H. pylori
virulence markers and H. pylori-associated diseases from
one geographic area to another. Therefore, the aim of the
present study was to assess the distribution of cagA, babA2,
and dupA in H. pylori strains from Malaysia’s multiethnic
population and to determine its association with clinical
outcomes.
2. Materials and methods
This was a prospective study conducted on 226 patients
who underwent routine endoscopies from July 2012 to
January 2014 in the endoscopy units of Hospital University
Sains Malaysia and Hospital Kuala Lumpur. Patients were
excluded from the study if they had received treatment
with antibiotics, proton pump inhibitors, H2 receptor
antagonists, or bismuth compounds within the 4 weeks
prior to the study. After the endoscopic examination, the
gastric biopsy specimens from the antrum were examined
for the presence of H. pylori by rapid urease tests, culture,
and histology.
This study was approved by the Human Research Ethics
Committee, University Sains Malaysia, Kubang Kerian,
Kelantan, Malaysia, and the National Medical Research
Registry. Written informed consent was obtained from
each patient prior to enrollment in the study.

2.1. Rapid urease test
Gastric antral biopsies were collected for the rapid urease
test (RUT). The diagnosis of infection was based on the
RUT, culture, and histology. All 105 biopsy samples tested
positive by RUT. Culture was performed on 81 samples,
out of which 33 samples tested positive for H. pylori. Out
of 30 samples diagnosed by histology, only 20 samples
proved positive for H. pylori. RUT was performed with a
solution of 1 mL of distilled water, one drop 1% of phenol
red, and 100 mg of urea. One antral biopsy sample was
placed in the solution immediately after endoscopy and
maintained at room temperature. The test was considered
positive when the color changed from yellow to red within
24 h (21).
2.2. Transport of samples
Biopsy samples for polymerase chain reaction (PCR) were
placed in 500 µL of Brucella broth with 20% (v/v) glycerol
and kept at –80 °C until processing (22).
2.3. Culture and identification of H. pylori
Gastric biopsy specimens were inoculated onto Columbia
agar base (Oxoid, UK) supplemented with 7% laked horse
blood and H. pylori Dent’s selective (containing 5.0 mg/
mL vancomycin, 2.5 mg/mL trimethoprim, 2.5 mg/mL
cefsulodin, and 2.5 mg/mL amphotericin B), and the plates
were incubated for 5‒7 days at 37 °C under microaerophilic
conditions. Organisms were identified as H. pylori by
Gram stain and oxidase, catalase, and urease tests.
2.4. DNA extraction
Genomic DNA was extracted from a gastric biopsy
using the QIAamp DNA tissue extraction kit (QIAGEN,
Germany) according to the manufacturer’s instructions
and the DNA was stored at –20 °C until analysis.
2.5. PCR amplifications and conditions
PCR amplifications of cagA, babA2, and dupA were carried
out with the use of the primers listed in Table 1 (23‒26).
The PCR reaction mixtures were prepared using the
TopTaq Master Mix Kit (QIAGEN) in a final volume of
25 µL containing 1.25 U of TopTaq DNA polymerase, 1X
PCR buffer, 1.5 mM MgCl2, 200 µM of each dNTP, 0.2 µM
of each primer, 10 μL of molecular grade water, and 2.5 µL
of DNA. The mixtures were placed in a PCR thermocycler
(Eppendorf, Germany).
The PCR conditions for cagA included an initial
denaturation of target DNA at 94 °C for 1 min, followed
by 35 cycles of denaturation at 94 °C for 1 min, primer
annealing at 58 °C for 1 min, and extension at 72 °C for
1 min, with final extension at 72 °C for 15 min. As for the
babA2 and dupA genes, the PCR conditions were: 35 cycles
of denaturation at 94 °C for 45 s, primer annealing at 52
°C for 45 s, and extension at 72 °C for 45 s. PCR products
were run on 1.5% agarose gels containing red gel in the
TBE buffer according to the manufacturer’s instructions.
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Table 1. Primers used for PCR amplification of cagA, babA2, and dupA genes.
Primer

Primer sequence (5′-3′)

Size base pairs

References

cagA-D008

GGTCAAAATGCGGTCATGG

297

(23,24)

cagA-R008

TTAGAATAATCAACAAACATCACGCCAT

babA2

CCAAACGAAACAAAAAGCGT

271

(25)

197

(26)

GCTTGTGTAAAAGCCGTCGT
dupA1

CGTGATCAATATGGATGCTT

dupA2

TCTTTCTAGCTTGAGCGA

2.6. Data analyses
Stata Version 11 (StataCorp, USA) was used for analysis.
The chi-square test or Fisher’s exact test was applied in
order to analyze variances in H. pylori virulence genes
among gastric ulcer (GU), DU, and gastritis. The statistical
significance was set at P < 0.05.
3. Results
3.1. Patients and H. pylori
Out of 226 patients, 105 (46.5%) were confirmed to be
infected with H. pylori by RUT. The infected patients
(57 males and 48 females) ranged from between 26 to 86
years old (mean age: 54.48 ± 12.94 years). Based on the
endoscopic findings, 77 patients were diagnosed with
nonulcer dyspepsia (NUD) or gastritis, 9 had GUs, 5 had
DUs, and 13 were normal.
3.2. Frequency of cagA, babA2, and dupA
cagA was detected in 73 (69.5%) of the biopsy samples.
The distribution of cagA among the three groups (Indian,
Malay and Chinese) was 29 (39.7%), 26 (35.6%), and 18
(24.7%), respectively (Table 2). The Indian population
exhibited the highest distribution of cagA compared to the
others.
The babA2 gene was observed in 43 (41.0%) patients
derived from biopsy samples. The distribution of
the babA2 gene among Indian, Malay, and Chinese
populations was 14 (32.6%), 17 (39.5%), and 12 (27.9%),
respectively (Table 2).

The dupA gene was also found in 24 (22.9%) biopsy
samples. The distribution of the dupA gene among Indian,
Malay, and Chinese inhabitants was 9 (37.5%), 9 (37.5%),
and 6 (25.0%), respectively (Table 2).
3.3. cagA, babA2, and dupA genes and clinical outcome
The prevalence of cagA was higher in the NUD group
(76.7%) than in the GU (11.0%), DU (4.1%), and normal
groups (8.2%). Similarly, babA2 was most prevalent in NUD
(77.1%) patients. dupA was more frequent in the NUD
group (75.0%) than in the others (Table 3). The endoscopic
findings (NUD, DU, GU, and normal group) were higher
in male patients (54.3%) than in females (45.7%). Overall,
there was no significant difference between cagA, babA2,
and dupA genes and clinical outcomes (Table 3).
A combination of cagA, babA2, and dupA was detected
in 15 biopsy samples and a combination of cagA and babA2
was noted in 38 biopsy samples. Twenty-one patients had a
combination of both cagA and dupA. A total of 16 biopsy
samples tested positive for babA2 and dupA, as indicated
in Table 4. There was no significant variance observed
between the combinations and clinical outcomes.
4. Discussion
The clinical development of H. pylori infection depends
on a combination of many factors pertaining to both the
host and the bacteria. Among the bacterial factors, studies
have revealed that certain H. pylori genotypes cause more
severe pathologies (27).

Table 2. Distribution of cagA, babA2, and dupA gene by ethnicity.

Ethnic group (n)
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cagA

babA2

dupA

Positive

Negative

Positive

Negative

Positive

Negative

Indian (37)

29 (39.7)

8 (25.0)

14 (32.6)

23 (37.1)

9 (37.5)

28 (34.6)

Malay (42)

26 (35.6)

16 (50.0)

17 (39.5)

25 (40.3)

9 (37.5)

33 (40.7)

Chinese (26)

18 (24.7)

8 (25)

12 (27.9)

14 (22.6)

6 (25.0)

20 (24.7)
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Table 3. Distribution of cagA, babA2, and dupA and clinical outcome in H. pylori-infected patients.
Sex

NUD
n (%)

GU
n (%)

DU
n (%)

Normal
n (%)

*P-value

Male

44 (56.4)

4 (44.4)

4 (80.0)

5 (38.5)

0.371

Female

34 (43.6)

5 (55.6)

1 (20.0)

8 (61.5)

cagA+

56 (76.7)

8 (11.0)

3 (4.1)

6 (8.2)

cagA -

22 (68.8)

1 (3.1)

2 (6.2)

7 (21.9)

babA2+

32 (74.4)

5 (11.6)

3 (7.0)

3 (7.0)

babA2-

46 (74.2)

4 (6.5)

2 (3.2)

10 (16.1)

dupA+

18 (75.0)

1 (4.2)

2 (8.3)

3 (12.5)

dupA-

60 (74.1)

8 (9.9)

3 (3.7)

10 (12.3)

Virulence genes
0.146
0.290
0.700

NUD = Nonulcer disease (gastritis); GU = gastric ulcer; DU = duodenal ulcer.
*Fisher’s exact test was applied.

Table 4. Combined cagA, babA2, and dupA genotypes and clinical outcome.
Virulence genes

NUD
n (%)

GU
n (%)

DU
n (%)

Normal
n (%)

*P-value

cagA+/babA2+/dupA+

11 (32.4

1 (20.0)

1 (33.3

2 (66.7)

0.678

cagA-/babA2-/dupA-

23 (67.6)

4 (80.0)

2 (66.7)

1 (33.3)

cagA+/babA2+

28 (82.4)

5 (100)

2 (66.7)

3 (100)

cagA-/babA2-

6 (17.6)

0 (0.0)

1 (33.3)

0 (0.0)

cagA+/dupA+

16 (47.1)

1 (20.0)

2 (66.7)

2 (66.7)

cagA-/dupA-

18 (52.9)

4 (80.0)

1 (33.3)

1 (33.3)

babA2+/dupA+

12 (35.3)

1 (20.0)

1 (33.3)

2 (66.7)

babA2-/dupA-

22 (64.7)

4 (80.0)

2 (66.7)

1 (33.3)

0.549
0.565
0.654

NUD = Nonulcer disease (gastritis); GU = gastric ulcer; DU = duodenal ulcer.
*Fisher’s exact test was applied.

In this study, we determined the frequency of cagA,
babA2, and dupA in dyspeptic patients. The prevalence of
cagA differs in every part of the world. The prevalence of
cagA is lower in Western countries (28,29) when compared
to East Asian countries, where cagA is present in more
than 90% of cases irrespective of clinical presentation (30).
The prevalence of cagA in this study was 69.5%; this
is slightly lower than reports from East Asian countries.
Studies conducted locally have reported differing
percentages. According to Ramelah et al., the prevalence of
cagA was 94% (31), while Amjad et al. reported 43% (32).
This divergence within the same country may well be due

to differences in sample size, primer sets, or the variety of
strains within the same country. In addition, the results of
this study did not elaborate on conclusive evidence linking
cagA with NUD patients; our results are in agreement with
supplementary studies in Asian countries (31,33) that
failed to find any association. However, various studies
have reported that cagA was statistically concomitant with
peptic ulcers (34,35).
babA2 attaches H. pylori to these cells, enabling delivery
of vacA and cagA toxins near the gastric epithelium
and therefore increasing gastric tissue damage (15). The
prevalence of the babA2 genotype in our study was 41.0%.
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Our results are consistent with a study conducted in China,
which reported a prevalence rate of 38.9% in dyspeptic
patients (36), but slightly lower than studies from Turkey
(53.8%) (34). Oliveira et al. discovered that babA2 was more
frequently found in patients with DU and gastric cancer (35).
The current study did not include a gastric cancer case and
DU accounts only for 4.8% of the studied population, so this
might have contributed to the low prevalence of babA2 in
our study. Gerhad et al. discovered that babA2 was associated
with peptic ulcer disease in Western populations (15). Our
study failed to find any substantial associations between
babA2 and the clinical outcome. This is in agreement with a
previous conducted study (18).
During the present study, 24 (22.9%) dupA-positive H.
pylori strains were observed in the patients’ biopsy samples.
Our data are in line with a study of Japanese patients (21.3%)
(6) and slightly lower than the findings of a study conducted
in China (35.3%) (37). The only other study performed in
Malaysia also unearthed a comparable prevalence of 21.3%
(38). dupA has been linked to an increased risk of DU and
a decreased risk of gastric cancer (6). In contrast, Lu et al.
(6) did not observe an association between dupA and DU in
East Asia. These differences in results might be due to strain
variations moving from one region to another. Furthermore,
the DU patients used in our study account for only 4.8% of
the study group, which prevents us from drawing a definitive
conclusion.

Combinations of two or three of the virulence genes
were not noticeably diverse among the NUD, GU, DU, and
normal groups in our study, although a study conducted
in Cuba reported a significant association between a
combination of cagA and babA2 genotypes (39).
In our study, NUD patients tended to have a higher
distribution of cagA (76.7%), babA2 (74.4%), and dupA
(75.0%) compared to peptic ulcer disease. Our result
is in agreement with a study from Iran, which found an
obviously much higher prevalence of the cagA gene (73%)
in NUD patients (40). Others have found a higher presence
of cagA in peptic ulcer disease patients than in NUD
(31,41). This dissimilarity might be due to an imbalance in
NUD and peptic ulcer disease cases.
In conclusion, although there is no association
between virulence genotypes and clinical outcomes in our
study, the lower prevalence of these genotypes in H. pyloripositive patients and variations among different ethnicities
indicates that there is strain variation among countries and
ethnic groups.
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